HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H959. A total of 4 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,200 | -11.7% | 6,000 | -16.7% | 0.00% | – |
| Q2 2023 | $259,704 | -13.9% | 7,200 | -8.9% | 0.00% | – |
| Q1 2023 | $301,701 | -88.0% | 7,900 | -82.1% | 0.00% | -100.0% |
| Q4 2022 | $2,509,290 | +145.0% | 44,100 | +70.3% | 0.00% | – |
| Q3 2022 | $1,024,000 | +32.3% | 25,900 | +47.2% | 0.00% | – |
| Q2 2022 | $774,000 | – | 17,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 10,100 | $385,719 | 0.00% |
| SIMPLEX TRADING, LLC | 4,500 | $171 | 0.00% |
| JANE STREET GROUP, LLC | 7,900 | $301,701 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |